This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Find out more here.

LARS™

Ligament Augmentation & Reconstruction System

LARS on black.jpgThe next generation in soft tissue internal fixation

The most advanced non-biological soft tissue treatment option, LARS provides a high performance alternative to autogenous and allogenous tissue reconstructions.

  • Patented free-fibre design concepts based on current kinematic principles2,4
  • Novel fibre treatment process facilitates excellent tissue in-growth1,2,3
  • Refined surgical techniques ensuring long term clinical product efficacy5

Stability | Versatility | Recovery  


References:

  1. Pelletier and Durand. Human fibroblast culture: in vitro study. Institut National de Recherche Appliquée (INRA) test report. Data to file. Corin Group 2005
  2. LARS laboratory testing. Data held on file, Corin Group PLC 2005
  3. Trieb et al., 2004. In vivo and in vitro cellular ingrowth into a new generation of artificial ligaments. European surgical research
  4.  Guidoin et al., 2000. Analysis of retieved polymer fibre based replacements for ACL. Biomaterials.
  5.  Ranger et al., 2010. Evaluation of reconstructive surgery using artificial ligaments in 71 acute knee dislocations. International Orthopaedics (SICOT)
Print this pageEmail this page